Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00367263 · ClinicalTrials.gov registry record · NA
Evaluation of Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary
A NA study of Asthma, sponsored by Allergy & Asthma Medical Group & Research Center.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT00367263: Completed NA study of Asthma, sponsored by Allergy & Asthma Medical Group & Research Center.
NCT00367263 is a NA study of Asthma that has completed, run by Allergy & Asthma Medical Group & Research Center. The registered enrollment target is 12 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00367263, a NA study of Asthma, has completed, sponsored by Allergy & Asthma Medical Group & Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to evaluate a traditional paper symptom diary system versus the VOCEL Mobile Diary. Subjects will be issued in a random order each system and asked their preference at the end of their participation.
Conditions Studied
Interventions
- DRUG Alvesco (Ciclesonide) 160 ug/day
Study Locations (1)
California
- Allergy & Asthma Medical Group & Research Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-10 |
| Est. Completion | 2006-11 |
| Phase | NA |
What the finished NCT00367263 record still lists
NCT00367263 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Alvesco (Ciclesonide) 160 ug/day is the first listed.
NCT00367263 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00367263 about?
NCT00367263 is a clinical study titled "Evaluation of Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary". This study is designed to evaluate a traditional paper symptom diary system versus the VOCEL Mobile Diary. Subjects will be issued in a random order each system and asked their preference at the end of their participation.
What is the current status of trial NCT00367263?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2006-10. Estimated completion is 2006-11.
What conditions does trial NCT00367263 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00367263?
The interventions under investigation include: Alvesco (Ciclesonide) 160 ug/day (DRUG).
Who is sponsoring clinical trial NCT00367263?
This trial is sponsored by Allergy & Asthma Medical Group & Research Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00367263 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00367263's enrollment target sits among peer trials
12 360th of 374 higher than 9 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia